Cosentino U - Search Results

1

Behind the glow: unveiling the nature of NanoLuc reactants and products.

Bonardi A, Turelli M, Moro G, Greco C, Cosentino U, Adamo C. Bonardi A, et al. Among authors: cosentino u. Phys Chem Chem Phys. 2024 Nov 7;26(43):27447-27458. doi: 10.1039/d4cp02551b. Phys Chem Chem Phys. 2024. PMID: 39446158

2

[Problems of patients with schizophrenic disorders and of their families].

Lanzara D, Cosentino U, Lo Maglio AM, Lora A, Nicolò A, Rossini MS. Lanzara D, et al. Among authors: cosentino u. Epidemiol Psichiatr Soc. 1999 Apr-Jun;8(2):117-30. doi: 10.1017/s1121189x00007624. Epidemiol Psichiatr Soc. 1999. PMID: 10540515 Italian.

3

Which community care for patients with schizophrenic disorders? Packages of care provided by Departments of Mental Health in Lombardy (Italy).

Lora A, Cosentino U, Gandini A, Zocchetti C. Lora A, et al. Among authors: cosentino u. Epidemiol Psichiatr Soc. 2007 Oct-Dec;16(4):330-8. Epidemiol Psichiatr Soc. 2007. PMID: 18333429

4

Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams.

Angelucci L, Calvisi P, Catini R, Cosentino U, Cozzolino R, De Witt P, Ghirardi O, Giannessi F, Giuliani A, Guaraldi D, et al. Angelucci L, et al. Among authors: cosentino u. J Med Chem. 1993 May 28;36(11):1511-9. doi: 10.1021/jm00063a001. J Med Chem. 1993. PMID: 8496921

5

Conformational characterization of lanthanide(III)-DOTA complexes by ab initio investigation in vacuo and in aqueous solution.

Cosentino U, Villa A, Pitea D, Moro G, Barone V, Maiocchi A. Cosentino U, et al. J Am Chem Soc. 2002 May 1;124(17):4901-9. doi: 10.1021/ja017666t. J Am Chem Soc. 2002. PMID: 11971741

6

Tetracycline and its analogues as inhibitors of amyloid fibrils: searching for a geometrical pharmacophore by theoretical investigation of their conformational behavior in aqueous solution.

Cosentino U, Varí MR, Saracino AA, Pitea D, Moro G, Salmona M. Cosentino U, et al. J Mol Model. 2005 Feb;11(1):17-25. doi: 10.1007/s00894-004-0213-x. Epub 2004 Dec 9. J Mol Model. 2005. PMID: 15592898

7

Conformational polymorphism of the PrP106-126 peptide in different environments: a molecular dynamics study.

Villa A, Mark AE, Saracino GA, Cosentino U, Pitea D, Moro G, Salmona M. Villa A, et al. Among authors: cosentino u. J Phys Chem B. 2006 Jan 26;110(3):1423-8. doi: 10.1021/jp052722o. J Phys Chem B. 2006. PMID: 16471693

8

The anti-fibrillogenic activity of tetracyclines on PrP 106-126: a 3D-QSAR study.

Cosentino U, Pitea D, Moro G, Saracino GA, Caria P, Varì RM, Colombo L, Forloni G, Tagliavini F, Salmona M. Cosentino U, et al. J Mol Model. 2008 Oct;14(10):987-94. doi: 10.1007/s00894-008-0348-2. Epub 2008 Jul 16. J Mol Model. 2008. PMID: 18629550

9

Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).

Saracino GA, Villa A, Moro G, Cosentino U, Salmona M. Saracino GA, et al. Among authors: cosentino u. Proteins. 2009 Jun;75(4):964-76. doi: 10.1002/prot.22306. Proteins. 2009. PMID: 19089953

10

Conformational behaviour determines the low-relaxivity state of a conditional MRI contrast agent.

Cosentino U, Pitea D, Moro G, Saracino GA, Villa A. Cosentino U, et al. Phys Chem Chem Phys. 2009 May 28;11(20):3943-50. doi: 10.1039/b902049g. Epub 2009 Apr 20. Phys Chem Chem Phys. 2009. PMID: 19440623

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters